About
HealthRegen is an Australian biotech startup at the forefront of disruptive preclinical and clinical solutions for global diabetes. Founded by a globally recognized stem cell biologist, MD, and now bioentrepreneur, HealthRegen are pioneering curative—not just symptomatic—treatments to redefine diabetes care.
Diabetes is a global epidemic, affecting 1 in 10 people (830 million, WHO 2024) and growing 2-3% annually. Current treatments (e.g., glucose-lowering drugs) fail to address the root cause, leading to:
• Devastating complications (heart/kidney failure, blindness, amputations, cancer).
• Reduced life expectancy (20 years for Type 1, 10 years for Type 2).
• Hypoglycemia risks for insulin-dependent patients.
At HealthRegen, we’re developing true cures—not just management.
For more information visit the HealthRegen.
Print this page
